Some observations on the intrinsic nervous mechanism in Hirschsprung's disease

Por Frigo, G. M., Del Tacca, M., Lecchini, S., Crema, A.
Publicado em 1973

Presence of a non-adrenergic inhibitory system in the human colon.

Por Crema, A, Del Tacca, M, Frigo, G M, Lecchini, S
Publicado em 1968

Effect of alpha 2-adrenoceptor agonists on gastric pepsin and acid secretion in the rat.

Por Tazi-Saad, K., Chariot, J., Del Tacca, M., Rozé, C.
Publicado em 1992

Somatostatin inhibits colon cancer cell growth through cyclooxygenase-2 downregulation

Por Colucci, R, Blandizzi, C, Ghisu, N, Florio, T, Del Tacca, M
Publicado em 2008

Reply to Dodds & Rivory

Por Blandizzi, C, De Paolis, B, Colucci, R, Lazzeri, G, Baschiera, F, Del Tacca, M
Publicado em 2001

Interaction between gemcitabine and topotecan in human non-small-cell lung cancer cells: effects on cell survival, cell cycle and pharmacogenetic profile

Por Giovannetti, E, Mey, V, Danesi, R, Basolo, F, Barachini, S, Deri, M, Del Tacca, M
Publicado em 2005

Fluvastatin synergistically enhances the antiproliferative effect of gemcitabine in human pancreatic cancer MIAPaCa-2 cells

Por Bocci, G, Fioravanti, A, Orlandi, P, Bernardini, N, Collecchi, P, Del Tacca, M, Danesi, R
Publicado em 2005

Involvement of basic fibroblast growth factor in suramin-induced inhibition of V79/AP4 fibroblast cell proliferation.

Por Bernardini, N., Giannessi, F., Bianchi, F., Dolfi, A., Lupetti, M., Citti, L., Danesi, R., Del Tacca, M.
Publicado em 1993

Suramin inhibits bFGF-induced endothelial cell proliferation and angiogenesis in the chick chorioallantoic membrane.

Por Danesi, R., Del Bianchi, S., Soldani, P., Campagni, A., La Rocca, R. V., Myers, C. E., Paparelli, A., Del Tacca, M.
Publicado em 1993

In vitro synergistic cytotoxicity of gemcitabine and pemetrexed and pharmacogenetic evaluation of response to gemcitabine in bladder cancer patients

Por Mey, V, Giovannetti, E, Braud, F De, Nannizzi, S, Curigliano, G, Verweij, F, De Cobelli, O, Pece, S, Del Tacca, M, Danesi, R
Publicado em 2006

Role of cyclooxygenases 1 and 2 in the modulation of neuromuscular functions in the distal colon of humans and mice

Por Fornai, M, Blandizzi, C, Colucci, R, Antonioli, L, Bernardini, N, Segnani, C, Baragatti, B, Barogi, S, Berti, P, Spisni, R, Del Tacca, M
Publicado em 2005

Cholecystokinin CCK(2) receptors mediate the peptide's inhibitory actions on the contractile activity of human distal colon via the nitric oxide pathway

Por Fornai, M, Colucci, R, Antonioli, L, Crema, F, Buccianti, P, Chiarugi, M, Baschiera, F, Ghisu, N, Tuccori, M, Blandizzi, C, Del Tacca, M
Publicado em 2007

Antiangiogenic and anticolorectal cancer effects of metronomic irinotecan chemotherapy alone and in combination with semaxinib

Por Bocci, G, Falcone, A, Fioravanti, A, Orlandi, P, Di Paolo, A, Fanelli, G, Viacava, P, Naccarato, A G, Kerbel, R S, Danesi, R, Del Tacca, M, Allegrini, G
Publicado em 2008

A pharmacokinetic and pharmacodynamic study on metronomic irinotecan in metastatic colorectal cancer patients

Por Allegrini, G, Falcone, A, Fioravanti, A, Barletta, M T, Orlandi, P, Loupakis, F, Cerri, E, Masi, G, Di Paolo, A, Kerbel, R S, Danesi, R, Del Tacca, M, Bocci, G
Publicado em 2008

Aurora B kinase inhibitor AZD1152: determinants of action and ability to enhance chemotherapeutics effectiveness in pancreatic and colon cancer

Por Azzariti, A, Bocci, G, Porcelli, L, Fioravanti, A, Sini, P, Simone, G M, Quatrale, A E, Chiarappa, P, Mangia, A, Sebastian, S, Del Bufalo, D, Del Tacca, M, Paradiso, A
Publicado em 2011

Prolonged fixed dose rate infusion of gemcitabine with autologous haemopoietic support in advanced pancreatic adenocarcinoma

Por Bengala, C, Guarneri, V, Giovannetti, E, Lencioni, M, Fontana, E, Mey, V, Fontana, A, Boggi, U, Del Chiaro, M, Danesi, R, Ricci, S, Mosca, F, Del Tacca, M, Conte, P F
Publicado em 2005